Actively Recruiting
French Pediatric Nationwide Observatory of Invasive Group A Streptococcal Infection in Children Ages 0 to 18
Led by Association Clinique Thérapeutique Infantile du val de Marne · Updated on 2024-02-08
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an observational study focused on pediatric patients hospitalized with invasive Group A Streptococcal infection. The study aims to identify and document cases of severe infections caused by Streptococcus pyogenes, evaluate the incidence of severe disease forms, explore contributing factors, and improve management strategies. Patients admitted to intensive or critical care units are also included to better understand the disease's impact. This study collects epidemiological, clinical, and bacteriological data on all cases of Group A Streptococcal infections, whether severe or not, to describe their characteristics and investigate reasons for recent increases in cases. Data will be gathered retrospectively and prospectively across participating centers, compiling information on infection severity and strain characteristics. Participants will be observed for one year, during which researchers will record hospitalizations, treatments in intensive care and routine care units, complications, risk factors, strain characterization, and mortality. The study focuses on collecting detailed medical data without assigning any treatment, allowing researchers to monitor disease outcomes and gather information to inform future care approaches.
CONDITIONS
Brief Title
Invasive Group A Streptococcal Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Under 18 years of age
- Confirmed invasive Group A Streptococcus infection by identification in sterile sites or in cases of toxin shock or necrotizing dermo-hypodermatitis
You will not qualify if you...
- Patient or legal representative refuses participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants who undergo routine care are observed to collect epidemiological, clinical, and bacteriological data related to invasive Group A Streptococcal infections.
Data collected during routine healthcare visits
Trial Site Locations
Total: 1 location
1
ACTIV
Créteil, France, 94000
Actively Recruiting
Research Team
L
Levy Corinne
B
Bechet Stephane
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here